Abstract
Atopic dermatitis (AD) in the elderly represents a newly defined subgroup of AD. Elderly patients with AD show some characteristic clinical manifestations. Skin manifestations of elderly AD basically match those of adolescent/adult AD, but a lack of involvement of the folds of the elbows and knees is more common than the classic sign of localized lichenification in those folds. Elderly patients with immunoglobulin (Ig)E-allergic AD show high rates of positivity for specific IgE antibodies against house dust mites. In immunohistopathology, IgE-mediated allergic inflammation with IgE+ mast cells and IgE+ dendritic cells (i.e., Langerhans cells and inflammatory dendritic cells) in association with environmental allergens (e.g., house dust mites) may exist in the lichenified eczema of IgE-allergic elderly AD. The prevalence of elderly AD, which shows a tendency toward a male predominance, is approximately 1–3% among elderly populations in industrialized countries. In clinical practice, most elderly patients with AD obtain amelioration of skin manifestations once suitable management is implemented, but most elderly patients with AD still reach the end of life with AD. AD should now be considered as a lifelong allergic condition in some populations.
The original version of this chapter was revised. An erratum to this chapter can be found at https://doi.org/10.1007/978-981-10-5541-6_30
References
Sulzberger MB, Goodman J. The relative importance of specific skin hypersensitivity in adult atopic dermatitis. JAMA. 1936;106:1000–3.
Nishioka K. Atopic eczema of adult type in Japan. Australas J Dermatol. 1996;37(Suppl):S7–9.
Tanei R, Katsuoka K. Clinical analyses of atopic dermatitis in the aged. J Dermatol. 2008;35:562–9.
Bozek A, Fisher A, Filipowska B, Mazur B, Jazab J. Clinical features and immunological markers of atopic dermatitis in elderly patients. Int Arch Allergy Immunol. 2012;157:372–8.
Bieber T, Bussmann C. Atopic dermatitis. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology, vol. 1. 3rd ed. Amsterdam: Elsevier; 2012. p. 203–17.
Tanei R. Atopic dermatitis in the elderly. Inflamm Allergy Drug Targets. 2009;8:394–404.
Tanei R. Atopic dermatitis in the elderly. Jpn J Allergol. 2015;64:918–25. (in Japanese)
Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Int. 2016;16(Suppl. 1):75–86.
Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113:651–7.
Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci. 2010;58:1–7.
Park JH, Choi YL, Namkung JH, Kim WS, Lee JH, Park HJ, et al. Characteristics of extrinsic and intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol. 2006;155:778–83.
Tanei R. Clinical characteristics, treatments, and prognosis of atopic eczema in the elderly. J Clin Med. 2015;4:979–97.
Smith CJ, Alexander LM, Kenney WL. Nonuniform, age-related decrements in regional sweating and skin blood flow. Am J Physiol Regul Integr Comp Physiol. 2013;305:R877–85.
Takahashi A, Murota H, Matsui S, Kijima A, Kitaba S, Lee JB, et al. Decreased sudomotor function is involved in the formation of atopic eczema in the cubital fossa. Allergol Int. 2013;62:473–8.
Shiohara T, Doi T, Hayakawa J. Defective sweating responses in atopic dermatitis. In: Shiohara T, editor. Pathogenesis and management of atopic dermatitis. Basel: Karger; 2011. p. 68–79.
Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S. IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol. 2002;82:335–40.
Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–94.
Benedetto AD, Agnihothri R, McGirt LY, Bankova LG, Beck LA. Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol. 2009;129:14–30.
Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70:3–11.
Eyerich K, Novak N. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy. 2013;68:974–82.
Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336–49.
Tanei R, Hasegawa Y, Sawabe M. Abundant immunoglobulin E-positive cells in skin lesions support an allergic etiology of atopic dermatitis in the elderly. J Eur Acad Dermatol Venereol. 2013;27:952–60.
Guttman-Yassky E, Lowes MA, Fuentes-Duculan J, Whynot J, Novitskaya I, Cardinale I, et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis. J Allergy Clin Immunol. 2007;119:1210–7.
Bruynzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruynzeel PL. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res. 1986;278:1993–205.
Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MAM, Kool M, et al. Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med. 2010;207:2097–111.
Katayama I, Tanei R, Yokozeki H, Nishioka K, Dohi Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody: possible implication for skin lesion formation in atopic dermatitis. Int Arch Allergy Appl Immunol. 1990;93:148–54.
Okada M, Terui T, Honda M, Tanaka M, Chikama R, Tabata N, et al. Cutaneous late phase reaction in adult atopic dermatitis patients with high serum IgE antibody to Dermatophagoides farinae: correlation with IL-5 production by allergen-stimulated peripheral blood mononuclear cells. J Dermatol Sci. 2002;29:73–84.
Thepen T, Langeveld-Wildschut EG, Bihari IC, van Wichen DF, van Reijsen FC, Mudde GC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: an immunocytochemical study. J Allergy Clin Immunol. 1996;97:828–37.
Bieber T. FcєRI-expressing antigen-presenting cells: new players in atopic game. Immunol Today. 1997;18:311–3.
Stingl G, Maurer D. IgE-mediated allergen presentation via Fc Epsilon Rl on antigen-presenting cells. Int Arch Allergy Immunol. 1997;113:24–9.
Maeda K, Yamamoto K, Tanaka Y, Anan S, Yoshida H. House dust mite (HDM) antigen in naturally occurring lesions of atopic dermatitis (AD): the relationship between HDM antigen in the skin and HDM antigen-specific IgE antibody. J Dermatol Sci. 1992;3:73–7.
Tanaka Y, Tanaka M, Anan S, Yoshida H. Immunohistochemical studies on dust mite antigen in positive reaction site of patch test. Acta Derm Venereol (Stockh). 1989;144:93–6.
Tanei R, Hasegawa Y. Double-positive immunoglobulin E+ and Dermatophagoides farinae antigen+ dendritic cells are observed in skin Lesions of older adults with atopic dermatitis: an immunohistological study. Dermatol Clin Res. 2017;3(1):134–50.
Novak N, Allam JP, Bieber T. Allergic hyperreactivity to microbial components: a trigger factor of “intrinsic” atopic dermatitis? J Allergy Clin Immunol. 2003;112:215–6.
Kerschenlohr K, Decard S, Darsow U, Ollert M, Wollenberg A. Clinical and immunologic reactivity to aeroallergens in “intrinsic” atopic dermatitis patients. J Allergy Clin Immunol. 2003:111:195–7.
Suárez-Farińas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman SC, et al. Intrinsic atopic dermatitis shows similar Th2 and higher Th17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132:361–70.
Thijs JL, van Seggelen W, Bruijnzeel-Koomen C, de Bruin-Weller M, Hijnen D. New developments in biomarkers for atopic dermatitis. J Clin Med. 2015;4:479–87.
Asai T, Horiuchi Y. Senile erythroderma with serum hyper IgE. Int J Dermatol. 1989;28:255–8.
Nakano-Tahara M, Terao M, Nishioka M, Kitaba S, Murota H, Katayama I. T helper 2 polarization in senile erythroderma with elevated levels of TARC and IgE. Dermatology. 2015;230:62–9.
Camacho FM, García-Hernandez MJ, Muñoz-Pérez MA, Mazuecos J, Sotillo I. Ofuji papuloerythroderma in elderly woman with atopic erythroderma. J Eur Acad Dermatol Venereol. 2001;15:264–6.
Miyagaki T, Sugaya M. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis. J Dermatol Sci. 2011;64:1–6.
Furue M, Chiba T, Takeuchi S. Current status of atopic dermatitis in Japan. Asia Pac Allergy. 2011;1:64–72.
Muto T, Hsieh SD, Sakurai Y, Yoshinaga H, Suto H, Okumura K, et al. Epidemiology and health services research prevalence of atopic dermatitis in Japanese adults. Br J Dermatol. 2003;148:117–21.
Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M, et al. The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol. 2003;38:1119–27.
Spergel JM, Poller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112:S118–27.
Brenninkmeijer EEA, Spuls PI, Legierse CM, Lindeboom R, Smitt JHS, Bos JD. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol. 2008;58:407–14.
Irvine AD, McLean WH. Filaggrin mutation associated with skin and allergic diseases. N Engl J Med. 2011;365:1315–27.
Nomura T, Akiyama M, Sandilands A, Nemoto-Hasebe I, Sakai K, Nagasaki A, et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol. 2008;128:1436–41.
Enomoto H, Hirata K, Otuka K, Kawai T, Takahashi T, Hirota T, et al. Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in Japanese population: a family and case-control study. J Hum Genet. 2008;53:615–21.
Tanei R, Noguchi E. Elderly atopic dermatitis in a father and daughter associated with MHC class II allele HLA-DRB1*1501. Dermatol Clin Res. 2016;2(3):95–8. ISSN:2380-5609.
Rice NE, Patel BD, Lang IA, Kumari M, Frayling TM, Murray A, et al. Filaggrin gene mutations are associated with asthma and eczema in later life. J Allergy Clin Immunol. 2008;122:834–6.
Katayama I, Kohno Y, Akiyama K, Ikezawa Z, Kondo N, Tamaki K, et al. Japanese guideline for atopic dermatitis. Allergol Int. 2011;60:205–20.
Tanei R, Oda A, Hasegawa Y. Narrow-band ultraviolet B is a useful adjunctive treatment for atopic dermatitis in older adults: case reports. Dermatol Clin Res. 2016;2(3):112–7.
Nakamura S, Takeda K, Hashimoto Y, Mizumoto T, Ishida-Yamamoto A, Iizuka H. Primary cutaneous CD30+ lymphoproliferative disorder in an atopic dermatitis patient on cyclosporine therapy. Indian J Dermatol Venereol Leprol. 2011;77:253.
Furue M, Kadono T. New therapies for controlling atopic itch. J Dermatol. 2015;42:847–50.
Novak N, Bieber T, Hoffmann M, Fölster-Holst R, Homey B, Werfel T, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130:925–31.
Acknowledgments
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. outside the USA
About this chapter
Cite this chapter
Tanei, R. (2018). Senile Atopic Dermatitis. In: Katayama, I., Murota, H., Satoh, T. (eds) Evolution of Atopic Dermatitis in the 21st Century. Springer, Singapore. https://doi.org/10.1007/978-981-10-5541-6_18
Download citation
DOI: https://doi.org/10.1007/978-981-10-5541-6_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5540-9
Online ISBN: 978-981-10-5541-6
eBook Packages: MedicineMedicine (R0)